Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pulmonology

How Doctors Diagnose Acute Interstitial Pneumonia

At a Glance

Acute Interstitial Pneumonia (AIP) is a severe, unexplained lung injury diagnosed by exclusion. Doctors use HRCT scans, fluid tests, and sometimes biopsies to identify Diffuse Alveolar Damage (DAD) while ruling out other causes like infections, drug toxicity, and autoimmune diseases.

When a patient arrives in the ICU with a sudden, severe respiratory crisis, doctors must act like detectives. To diagnose Acute Interstitial Pneumonia (AIP), they have to look deep into the lungs while simultaneously ruling out dozens of other possibilities. This process is a race to identify the specific pattern of injury and find any hidden triggers.

The Microscopic Evidence: DAD

The hallmark of AIP is a pathological pattern called Diffuse Alveolar Damage (DAD) [1][2]. It is not a disease itself, but a way the lungs react to extreme injury. In AIP, DAD progresses through three distinct, often overlapping phases:

  • Exudative Phase (Early): Within the first week, the lungs are flooded with fluid and protein. Under a microscope, doctors see hyaline membranes—thick, waxy ribbons that line the air sacs and block oxygen from reaching the blood [3][4].
  • Organizing Phase (Middle): The body tries to heal. Cells begin to multiply rapidly to “patch” the damage. This is often called the proliferative phase [3][5].
  • Fibrotic Phase (Late): In some cases, the repair process goes into overdrive, replacing soft lung tissue with stiff, scarred tissue (fibrosis) [6][5].

AIP vs. ARDS: The “Unknown” Factor

AIP and Acute Respiratory Distress Syndrome (ARDS) can look identical under a microscope and on a CT scan [1]. The primary difference is the trigger.

  • ARDS has a known cause, such as a severe infection (sepsis), major trauma, or inhaled toxins [5].
  • AIP is idiopathic, meaning it occurs “out of the blue” without a known external trigger [7][8].

Seeing Through the Lungs: HRCT

Doctors use High-Resolution Computed Tomography (HRCT) to “see” which phase the lungs are in.

  • Early Findings: You may hear the term ground-glass opacities. On the scan, these look like hazy, gray patches, representing the fluid and inflammation of the exudative phase [1][9].
  • Later Findings: If the disease progresses, the scan may show reticulation (a net-like pattern of scars) or traction bronchiectasis (where scarring pulls the airways open into abnormal shapes) [1][10].

The Rule-Out Process

A diagnosis of AIP is a “diagnosis of exclusion.” Doctors must prove it isn’t something else before confirming AIP.

  1. Infection: This is ruled out via Bronchoalveolar Lavage (BAL), where a small amount of fluid is washed into the lung and then pulled back out to be tested for bacteria, viruses, or fungi.
  2. Drug Toxicity: Certain medications (like chemotherapy drugs or certain heart medicines) can cause an identical lung reaction [11].
  3. Autoimmune Disease: Conditions like lupus or myositis can attack the lungs. Doctors run serology (blood tests) to look for autoantibodies [12][13]. If features of an autoimmune disease are present but not fully diagnostic, it may be called Interstitial Pneumonia with Autoimmune Features (IPAF) [11][14].

The Role of Biopsy

Sometimes, blood tests and scans aren’t enough. A lung biopsy—taking a small piece of tissue—can confirm the DAD pattern.

  • Surgical Lung Biopsy (SLB): The traditional “gold standard,” but it carries significant risks for a patient who is already very ill and on a ventilator [15][16].
  • Transbronchial Cryobiopsy (TBCB): A newer, less invasive technique. Doctors use a freezing probe through a thin tube (bronchoscope) to take a sample. It is generally safer than surgery and is increasingly used in ICU settings to get answers without the risks of a full operation [17][18][19].

Diagnostic Completeness Checklist

If you are advocating for a loved one, you can ask the medical team if these steps have been completed:

  • [ ] Infection Screen: Have BAL cultures and viral PCRs come back negative?
  • [ ] Drug Review: Has every medication taken in the last month been screened for lung toxicity?
  • [ ] Autoimmune Panel: Has a full “myositis” and “connective tissue” blood panel been completed?
  • [ ] Multidisciplinary Review: Have the radiologist, pulmonologist, and pathologist reviewed the scans and samples together? [20]

Common questions in this guide

What is the difference between AIP and ARDS?
Acute Interstitial Pneumonia (AIP) and Acute Respiratory Distress Syndrome (ARDS) look identical on scans and under a microscope. The main difference is the trigger: ARDS has a known cause like a severe infection or trauma, while AIP occurs suddenly without any known trigger.
What is Diffuse Alveolar Damage (DAD)?
Diffuse Alveolar Damage is a pattern of extreme lung injury seen under a microscope. In AIP, it progresses from an early phase with fluid buildup to a middle phase where the body tries to heal, and sometimes to a late phase that causes stiff scar tissue in the lungs.
Why do doctors need to rule out other conditions to diagnose AIP?
AIP is a diagnosis of exclusion, meaning doctors must first prove the lung injury isn't caused by something else. They run blood tests and analyze lung fluid to ensure the sudden breathing crisis isn't due to a hidden infection, a drug reaction, or an autoimmune disease.
What is a transbronchial cryobiopsy?
Transbronchial cryobiopsy is a minimally invasive procedure where doctors use a freezing probe passed through a thin tube to take a lung tissue sample. It is increasingly used in the ICU as a safer alternative to a traditional surgical lung biopsy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How are we distinguishing this from ARDS? Have all potential triggers like infection or trauma been fully ruled out?
  2. 2.What phase of injury (exudative or fibrotic) does the HRCT suggest, and how does that change our treatment approach?
  3. 3.What specific autoantibodies (like myositis panels or ANCA) have been tested to ensure this isn't an autoimmune flare?
  4. 4.If we need a biopsy, is transbronchial cryobiopsy (TBCB) available as a safer alternative to a surgical biopsy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.

    Nishino M, Kusumoto M, Bankier AA, et al.

    JCO precision oncology 2023; (7()):e2300391 doi:10.1200/PO.23.00391.

    PMID: 38061008
  2. 2

    COVID-19 Autopsies: A Case Series from Poland.

    Chmielik E, Jazowiecka-Rakus J, Dyduch G, et al.

    Pathobiology : journal of immunopathology, molecular and cellular biology 2021; (88(1)):78-87 doi:10.1159/000512768.

    PMID: 33254171
  3. 3

    COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS.

    Malik P, Patel K, Akrmah M, et al.

    SN comprehensive clinical medicine 2021; (3(12)):2407-2434 doi:10.1007/s42399-021-01029-5.

    PMID: 34396046
  4. 4

    COVID-19 post-mortem findings: how the departed can teach us.

    Nimir M, Tank A, Snead D

    Diagnostic histopathology (Oxford, England) 2021; (27(10)):422-424 doi:10.1016/j.mpdhp.2021.07.003.

    PMID: 34341671
  5. 5

    Pathological post-mortem findings in lungs infected with SARS-CoV-2.

    Damiani S, Fiorentino M, De Palma A, et al.

    The Journal of pathology 2021; (253(1)):31-40 doi:10.1002/path.5549.

    PMID: 32930394
  6. 6

    Histopathological autopsy findings in lungs of pregnant and postpartum women who died of COVID-19 infections.

    Bisharyan MS, Arsenyan KA, Khachatryan PS, et al.

    Rechtsmedizin (Berlin, Germany) 2023; 1-7 doi:10.1007/s00194-023-00618-z.

    PMID: 37363653
  7. 7

    A 45-Year-Old Woman with Acute Interstitial Pneumonia (Hamman-Rich Syndrome).

    Chertoff J, Alnuaimat H

    Turkish journal of anaesthesiology and reanimation 2017; (45(4)):244 doi:10.5152/TJAR.2017.98105.

    PMID: 28868178
  8. 8

    Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review.

    Puseljic M, Schmid J, Igrec J, et al.

    ARP rheumatology 2024; (3(2)):151-156.

    PMID: 38956997
  9. 9

    High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation: based on the updated concept of idiopathic pneumonia syndrome by the American Thoracic Society in 2011.

    Tanaka N, Kunihiro Y, Kobayashi T, et al.

    Clinical radiology 2016; (71(10)):953-959 doi:10.1016/j.crad.2016.06.109.

    PMID: 27421574
  10. 10

    Advances in Concept and Imaging of Interstitial Lung Disease.

    Yanagawa M, Han J, Wada N, et al.

    Radiology 2025; (315(2)):e241252 doi:10.1148/radiol.241252.

    PMID: 40358445
  11. 11

    [The concept of interstitial pneumonia with autoimmune features (IPAF)].

    Bermudez J, Habert P, Coiffard B

    La Revue de medecine interne 2024; (45(6)):343-349 doi:10.1016/j.revmed.2024.02.005.

    PMID: 38433068
  12. 12

    Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study.

    Libra A, Muscato G, Ielo G, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(11)) doi:10.3390/diagnostics13111882.

    PMID: 37296734
  13. 13

    Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies.

    Lhote R, Grenier P, Haroche J, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2020; (26(8)):327-333 doi:10.1097/RHU.0000000000001127.

    PMID: 31415476
  14. 14

    Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases.

    Hernandez-Gonzalez F, Prieto-González S, Brito-Zeron P, et al.

    Medicine 2020; (99(4)):e18589 doi:10.1097/MD.0000000000018589.

    PMID: 31977850
  15. 15

    Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008.

    Hutchinson JP, McKeever TM, Fogarty AW, et al.

    The European respiratory journal 2016; (48(5)):1453-1461 doi:10.1183/13993003.00378-2016.

    PMID: 27660509
  16. 16

    In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

    Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB

    American journal of respiratory and critical care medicine 2016; (193(10)):1161-7 doi:10.1164/rccm.201508-1632OC.

    PMID: 26646481
  17. 17

    Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

    Raghu G, Remy-Jardin M, Richeldi L, et al.

    American journal of respiratory and critical care medicine 2022; (205(9)):e18-e47 doi:10.1164/rccm.202202-0399ST.

    PMID: 35486072
  18. 18

    Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial.

    Kalverda KA, Ninaber MK, Wijmans L, et al.

    The Lancet. Respiratory medicine 2024; (12(7)):513-522 doi:10.1016/S2213-2600(24)00074-2.

    PMID: 38640934
  19. 19

    Extracorporeal Membrane Oxygenation Supported Transbronchial Cryobiopsy in the Diagnosis of Severe Organizing Pneumonia: A Case Report.

    Zhang X, Wang Y, Feng Y, et al.

    Frontiers in medicine 2022; (9()):955992 doi:10.3389/fmed.2022.955992.

    PMID: 35911395
  20. 20

    Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE).

    Fortin M, Liberman M, Delage A, et al.

    American journal of respiratory and critical care medicine 2023; (207(12)):1612-1619 doi:10.1164/rccm.202209-1812OC.

    PMID: 36796092

This page explains the diagnostic process for acute interstitial pneumonia for educational purposes only. Always consult with your critical care team or pulmonologist for specific medical guidance and interpretation of test results.

Get notified when new evidence is published on Acute interstitial pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.